Beta: Sign in
Shares outstandingAs of 2026-08-13 · filed common shares: 21.56M
Shares float: Sign in
Float %: Sign in
Insider ownershipDirectors and officers, from their latest Form 3/4/5 holding: 8.81%
Institutional ownership: Sign in
Short interestShare of shares outstanding, at settlement: 2.93%
Short ratioDays to cover, as published by FINRA: 1.00
Short volume (5D)Share of FINRA reporting-facility volume sold short, daily flow: 30.70%
Short volume (20D)Share of FINRA reporting-facility volume sold short, daily flow: 37.40%
Avg volume (10D)

See the full stock page

Prices, charts, ranges, valuation ratios, dividends, momentum and analyst estimates are licensed for signed-in members. A free account opens every stock, fund and crypto page.

Create free account

Source: SEC filings. Information and analytics, not investment advice.

Loading evidence for MGRX

Rev growth (fwd)

Avg volume (3 months)

Profitability

Gross marginTTM to Jun 26: 54.43%
Operating marginTTM to Jun 26: -3829.00%
Net margin: —
EBITDA marginTTM to Jun 26: -3471.97%
Return on equityNet income (TTM to Jun 26) ÷ average shareholders equity: -95.08%
Return on assetsNet income (TTM to Jun 26) ÷ average total assets: -86.27%

Growth

Revenue growth (annual YoY): -25.96%
Revenue growth (latest qtr YoY): -59.10%
Revenue growth (fwd): Sign in
Net income growth (annual YoY): —
Net income growth (latest qtr YoY): —
EPS growth (fwd): Sign in
Net income growth (QoQ): —

Valuation

Market cap: Sign in
Enterprise value: Sign in
P/E: Sign in
P/E (fwd): Sign in
PEG: Sign in
PEG (fwd): Sign in
Price / book: Sign in
Price / sales: Sign in
Price / operating cash flow: Sign in
P/FCF: Sign in
EV / revenue: Sign in
EV / EBITDA: Sign in
EPSDiluted, TTM to Jun 26: -1.00
EPS (fwd): Sign in

Financial health

Cash & equivalentsas of Jun 26: $228.68K
Total cash: Sign in
Total debtBorrowings + finance and operating lease liabilities, as of Jun 26: $279.20K
Debt / equityas of Jun 26: 2.23%
Current ratioas of Jun 26: 0.18
Quick ratio: —
Operating cash flowTTM to Jun 26: -$3.89M
Free cash flow (quarter)Quarter: 2024-10-01 to 2024-12-31 · Not annualized: -$1.12M
TTM revenue / diluted shareDiluted, TTM to Jun 26: 0.02

MGRX stock Statistics — Mangoceuticals, INC. filings, insiders & smart money · Instaport